During the past decade, Neuromuscular Research Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuromuscular Research Center" #1 sponsor was "Amicus Therapeutics" with 3 trials, followed by "Sarepta Therapeutics, Inc." with 3 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored, "Mitsubishi Tanabe Pharma America Inc." with 2 trials sponsored and "BioMarin Pharmaceutical" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuromuscular Research Center" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Neuromuscular Research Center" are "Duchenne Muscular Dystrophy" (3 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Pompe Disease (Late-onset)" (2 trials) and "ALS" (1 trials). Many other conditions were trialed in "Neuromuscular Research Center" in a lesser frequency.

Most popular intervention types in "Neuromuscular Research Center" are "Drug" (13 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "AT2221" (2 trials), "ATB200" (2 trials), "HYQVIA" (2 trials), "MT-1186" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neuromuscular Research Center" are 11 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Neuromuscular Research Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Neuromuscular Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neuromuscular Research Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".